NYLI Global Equity R&D Leaders ETF (WRND) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
NYLI Global Equity R&D Leaders ETF (WRND) operates in the Financial Services sector, specifically the Asset Management - Global industry, with a market capitalization near $10.2M, listed on NASDAQ, carrying a beta of 1.11 to the broader market. NYLI Global Equity R&D Leaders ETF (WRND) seeks investment results that track, before fees and expenses, the price and yield performance of the NYLI Global Equity R&D Leaders Index, an index that seeks to provide exposure to innovative companies by investing in the equity securities of global companies that demonstrate consistent and effective use of R&D investment. public since 2022-02-08.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for WRND as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.